NIFTY  8,907.85  0.32%
  SENSEX  28,761.60  0.35%
 CURRENCY  Rs  66.93/$ 70.86/€, 83.36/£
  GOLD  29,104.00  -0.68%
  SILVER  42,438.00  -1.08%
  DAX  11,827.60  0.60%
  FTSE  7,299.86  -0.00%
  CAC  4,864.99  -0.04%
  HANG SENG  23,963.60  -0.76%
  NIKKEI  19,381.40  0.68%
  Shanghai Composite  3,253.33  0.23%
  DOW JONES  20,624.10  0.02%
  NASDAQ  5,838.58  0.41%
  S&P 500  2,351.16  0.17%
GOVT OFFICIAL - Govt To Sell 5% Stake In Bharat Electronics On Feb 22 GOVT OFFICIAL - Govt Aims To Raise About Rs 1,600 Cr From BEL Divestment

Don't See Issues On SEBI Front: Sun Pharma

Video:

Play this video

April 9: Speaking to Harsha Subramaniam Sun Pharma Chairman Israel Makov seems expectedly gung-ho on what could be India's largest drug company. He adds, that the company’s regulatory compliance will help them deal with the regulatory problems that Ranbaxy is facing with the U.S. FDA. He also points out that Sun Pharma has not yet heard from SEBI regarding a subsidiary picking up Ranbaxy stock a few months before this transaction.